1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Gaming and Leisure Properties reported first-quarter 2026 total revenue of $420.0 million, up 6.3% from a year earlier, and net income of $239.4 million, or $0.82 per diluted share, compared with $0.60 a year earlier. The company raised its 2026 AFFO per share guidance to $4.08 to $4.12 from $4.06 to $4.11, which points to higher expected cash earnings for shareholders.
Total revenue was $420.0 million for the three months ended March 31, 2026, versus $395.2 million a year earlier.
Net income was $239.4 million, or $0.82 per diluted share, versus $170.4 million, or $0.60 per diluted share, a year earlier.
2026 AFFO guidance is now $1.212 billion to $1.223 billion, or $4.08 to $4.12 per diluted share and OP/LTIP units, up from $4.06 to $4.11.
Financial leverage was 5.0x net debt to adjusted EBITDA as of March 31, 2026, the low end of the company's 5.0x to 5.5x target range.
Texas Community Bancshares reported unaudited net income of $836,000 for the first quarter ended March 31, 2026, up 30.0% from $643,000 a year earlier. Net interest margin widened to 3.49% from 3.24%, while noninterest expense rose 8.2%, so the earnings gain came from higher interest margin and noninterest income.
Net income was $836,000 for the three months ended March 31, 2026, compared with $643,000 a year earlier.
Net interest income rose $103,000, or 3.1%, to $3.4 million, and net interest margin rose to 3.49% from 3.24%.
Noninterest expense increased $240,000, or 8.2%, to $3.2 million, mainly due to costs tied to a foreclosed multifamily property and technology spending.
Total deposits were $332.0 million at March 31, 2026, and nonperforming assets were $11.2 million, or 2.60% of total assets.
Procter & Gamble reported third-quarter fiscal 2026 results with organic sales up 3% and core earnings per share up 3% to $1.59, while currency-neutral core EPS was flat at $1.54. The company maintained its fiscal 2026 guidance, including core EPS growth of 0% to 4%, though core operating margin fell 80 basis points to 22.2%.
Organic sales grew 3%, with volume up 2% and pricing up 1%; diluted EPS was $1.63 versus $1.54 a year earlier.
Core gross margin was 50.0%, down 100 basis points, and core operating margin was 22.2%, down 80 basis points.
FY 2026 guidance was maintained: organic sales growth of 0% to 4%, core EPS growth of 0% to 4%, and all-in EPS growth of 1% to 6%.
Clorox bought P&G's minority interest in the Glad joint venture for $476 million, producing an after-tax gain of $261 million that was excluded from core EPS.
Moog reported fiscal second quarter 2026 net sales of $1.05 billion, up 13% from $934 million a year earlier, with diluted earnings per share of $2.55 versus $1.71. The company raised its fiscal 2026 adjusted diluted earnings per share guidance to $10.60 from $10.20 and also declared a $0.30 per share quarterly dividend.
Q2 net sales $1.05 billion vs. $934 million; diluted EPS $2.55 vs. $1.71
Adjusted diluted EPS $2.64 vs. $1.88; free cash flow $98 million vs. $2 million
FY2026 adjusted diluted EPS guidance raised to $10.60 from $10.20; adjusted operating margin and free cash flow conversion guidance reaffirmed
Quarterly dividend of $0.30 per share payable May 21, 2026 to holders of record May 12, 2026
Tompkins Financial reported first quarter 2026 diluted earnings per share of $1.82 and net income of $26.1 million, both up about a third from a year earlier, which the company called a record first quarter. Results were far below the fourth quarter of 2025, which included income from the sale of Tompkins Insurance Agencies. The board also declared a $0.67 per share dividend payable May 15, 2026.
Diluted EPS of $1.82 for Q1 2026, up 32.8% from $1.37 in Q1 2025 and down from $6.70 in Q4 2025
Net income of $26.1 million, up 32.5% year over year; Q4 2025 included the sale of Tompkins Insurance Agencies
Net interest margin of 3.57%, up from 2.98% in Q1 2025; net interest income of $71.9 million, up 26.8%
Dividend of $0.67 per share declared April 23, 2026, payable May 15, 2026, to holders of record May 8, 2026
Gentex reported first-quarter 2026 consolidated net sales of $675.4 million, up 17% from $576.8 million a year earlier, with $88.6 million coming from the VOXX business it acquired. GAAP earnings were $0.46 per diluted share, up from $0.42, and the company raised its 2026 consolidated revenue guidance to $2.65 billion to $2.75 billion while keeping its gross margin outlook unchanged. The filing also flags tariff and commodity cost pressures and possible but unrecognized IEEPA tariff refunds.
Q1 2026 GAAP net income attributable to Gentex was $98.5 million, or $0.46 per diluted share, versus $94.9 million, or $0.42, in Q1 2025
2026 consolidated revenue guidance raised to $2.65 billion to $2.75 billion from $2.60 billion to $2.70 billion; gross margin guidance of 34% to 35% unchanged
Core Gentex net sales were $586.8 million; the company repurchased 3.3 million shares for $71.6 million in the quarter
HCA Healthcare reported first-quarter 2026 revenues of $19.109 billion, up 4.3%, and diluted earnings per share of $7.15, up 10.9% from $6.45 a year earlier. The company reaffirmed its 2026 guidance and declared a quarterly dividend of $0.78 per share, payable June 30, 2026.
Revenues rose 4.3% to $19.109 billion; net income attributable to HCA Healthcare was $1.620 billion, up 0.6%.
Adjusted EBITDA rose 1.9% to $3.802 billion, though its margin fell to 19.9% from 20.4%.
Respiratory-related admissions fell 42%, and a January winter storm hurt volumes; Medicaid supplemental programs not in initial guidance offset much of the impact.
Guidance reaffirmed for 2026, including diluted EPS of $29.10 to $31.50; the company repurchased 3.157 million shares for $1.571 billion in the quarter.
Sensient Technologies reported first-quarter 2026 revenue of $435.8 million, up 11.1% from a year earlier, and diluted earnings per share of $1.04, up from 81 cents. The company raised its 2026 GAAP diluted EPS guidance to $3.70 to $3.90 from $3.60 to $3.80, which benefits shareholders if the results hold.
Q1 2026 revenue rose 11.1% to $435.8 million; local currency revenue rose 7.2%.
Operating income rose 24.7% to $66.7 million; Q1 2025 included $2.9 million of Portfolio Optimization Plan costs.
2026 GAAP diluted EPS guidance raised to $3.70 to $3.90 from $3.60 to $3.80.
Net cash used in operating activities was $13.6 million in Q1 2026, compared with $9.0 million a year earlier.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.